Literature DB >> 22923420

Pooled DNA resequencing of 68 myocardial infarction candidate genes in French canadians.

Mélissa Beaudoin1, Ken Sin Lo, Amidou N'Diaye, Manuel A Rivas, Marie-Pierre Dubé, Nathalie Laplante, Michael S Phillips, John D Rioux, Jean-Claude Tardif, Guillaume Lettre.   

Abstract

BACKGROUND: Familial history is a strong risk factor for coronary artery disease (CAD), especially for early-onset myocardial infarction (MI). Several genes and chromosomal regions have been implicated in the genetic cause of coronary artery disease/MI, mostly through the discovery of familial mutations implicated in hyper-/hypocholesterolemia by linkage studies and single nucleotide polymorphisms by genome-wide association studies. Except for a few examples (eg, PCSK9), the role of low-frequency genetic variation (minor allele frequency [MAF]) ≈0.1%-5% on MI/coronary artery disease predisposition has not been extensively investigated. METHODS AND
RESULTS: We selected 68 candidate genes and sequenced their exons (394 kb) in 500 early-onset MI cases and 500 matched controls, all of French-Canadian ancestry, using solution-based capture in pools of nonindexed DNA samples. In these regions, we identified 1852 single nucleotide variants (695 novel) and captured 85% of the variants with MAF≥1% found by the 1000 Genomes Project in Europe-ancestry individuals. Using gene-based association testing, we prioritized for follow-up 29 low-frequency variants in 8 genes and attempted to genotype them for replication in 1594 MI cases and 2988 controls from 2 French-Canadian panels. Our pilot association analysis of low-frequency variants in 68 candidate genes did not identify genes with large effect on MI risk in French Canadians.
CONCLUSIONS: We have optimized a strategy, applicable to all complex diseases and traits, to discover efficiently and cost-effectively DNA sequence variants in large populations. Resequencing endeavors to find low-frequency variants implicated in common human diseases are likely to require very large sample size.

Entities:  

Mesh:

Year:  2012        PMID: 22923420     DOI: 10.1161/CIRCGENETICS.112.963165

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  8 in total

1.  Myocardial Infarction-Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries.

Authors:  Mélissa Beaudoin; Rajat M Gupta; Hong-Hee Won; Ken Sin Lo; Ron Do; Christopher A Henderson; Claire Lavoie-St-Amour; Simon Langlois; Daniel Rivas; Stephanie Lehoux; Sekar Kathiresan; Jean-Claude Tardif; Kiran Musunuru; Guillaume Lettre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

2.  Whole-genome sequencing in French Canadians from Quebec.

Authors:  Cécile Low-Kam; David Rhainds; Ken Sin Lo; Sylvie Provost; Ian Mongrain; Anick Dubois; Sylvie Perreault; John F Robinson; Robert A Hegele; Marie-Pierre Dubé; Jean-Claude Tardif; Guillaume Lettre
Journal:  Hum Genet       Date:  2016-07-04       Impact factor: 4.132

Review 3.  Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations.

Authors:  Lang Wu; Daniel J Schaid; Hugues Sicotte; Eric D Wieben; Hu Li; Gloria M Petersen
Journal:  J Med Genet       Date:  2014-11-04       Impact factor: 6.318

4.  Rare variant association studies: considerations, challenges and opportunities.

Authors:  Paul L Auer; Guillaume Lettre
Journal:  Genome Med       Date:  2015-02-23       Impact factor: 11.117

Review 5.  Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9).

Authors:  Rainer Schulz; Klaus-Dieter Schlüter; Ulrich Laufs
Journal:  Basic Res Cardiol       Date:  2015-01-20       Impact factor: 17.165

6.  Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits.

Authors:  Paul L Auer; Alexander Teumer; Ursula Schick; Andrew O'Shaughnessy; Ken Sin Lo; Nathalie Chami; Chris Carlson; Simon de Denus; Marie-Pierre Dubé; Jeff Haessler; Rebecca D Jackson; Charles Kooperberg; Louis-Philippe Lemieux Perreault; Matthias Nauck; Ulrike Peters; John D Rioux; Frank Schmidt; Valérie Turcot; Uwe Völker; Henry Völzke; Andreas Greinacher; Li Hsu; Jean-Claude Tardif; George A Diaz; Alexander P Reiner; Guillaume Lettre
Journal:  Nat Genet       Date:  2014-04-28       Impact factor: 38.330

7.  Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation.

Authors:  Chia-Ti Tsai; Chia-Shan Hsieh; Sheng-Nan Chang; Eric Y Chuang; Kwo-Chang Ueng; Chin-Feng Tsai; Tsung-Hsien Lin; Cho-Kai Wu; Jen-Kuang Lee; Lian-Yu Lin; Yi-Chih Wang; Chih-Chieh Yu; Ling-Ping Lai; Chuen-Den Tseng; Juey-Jen Hwang; Fu-Tien Chiang; Jiunn-Lee Lin
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

8.  Variants at the APOE /C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High-Density Lipoprotein Cholesterol.

Authors:  Cécile Low-Kam; David Rhainds; Ken Sin Lo; Amina Barhdadi; Marie Boulé; Sonia Alem; Valérie Pedneault-Gagnon; Eric Rhéaume; Marie-Pierre Dubé; David Busseuil; Robert A Hegele; Guillaume Lettre; Jean-Claude Tardif
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.